Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2010-05-11 Earnings Release
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC Announces Financial Results for the First Quarter 2010
Earnings Release Classification · 98% confidence The document is explicitly titled "4SC Announces Financial Results for the First Quarter 2010" and provides key financial highlights (revenue, expenses, operating loss, EPS) and operational updates for the period ending March 31, 2010. This content structure—announcing period results with key figures and commentary—is characteristic of an Earnings Release (ER). Although it mentions the 'complete quarterly report' is available elsewhere, the document itself is the initial announcement of those results, making ER the most appropriate classification over IR (Interim Report) or RPA (Report Publication Announcement). The length (8490 chars) is substantial enough to be the release itself, not just a brief notice. Q1 2010
2010-05-11 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2009 bis zum 31.12.2009
Annual Report Classification · 100% confidence The document is a comprehensive financial report for the fiscal year 2009, titled 'Jahresabschluss 2009' (Annual Financial Statements 2009) for 4SC AG. It includes a balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), and detailed notes (Anhang zum Jahresabschluss). While it is a full annual report, the provided text is a segment of the official German statutory filing. Given the comprehensive nature of the financial data and the inclusion of the management report (Lagebericht) and audit opinion (Bestätigungsvermerk), it falls under the category of an Annual Report. FY 2009
2010-05-11 German
4SC Q1 2010 Results Conference Call 11 May, 2010
Report Publication Announcement Classification · 99% confidence The document explicitly announces that 4SC AG "will announce its results for the first quarter (ended 31 March) on 11 May, 2010" and that the "senior management team will host a conference call at 3pm CET (9am EST) on the day to inform about the results for the quarter". This is an announcement about an upcoming earnings-related conference call, not the transcript of the call itself, nor the full quarterly report (IR) or the initial earnings release (ER) highlights. Since the primary content is the scheduling and access details for a conference call where results will be discussed, the most appropriate classification is Call Transcript (CT), as this category covers conference call information, even if it's just the announcement/details for the call itself, which often precedes the actual transcript being filed. Given the options, CT is the best fit for scheduling an earnings call.
2010-05-04 English
DGAP-DD: 4SC AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information about a transaction (purchase) made by a person performing managerial responsibilities ('Member of a managing body'). This directly corresponds to the definition of Director's Dealing, which maps to the filing code DIRS.
2010-04-28 English
4SC Publishes Preclinical Data on Vidofludimus (4SC-101) in Peer-Review Journals
Environmental & Social Information Classification · 99% confidence The document is dated April 28, 2010, and is titled '4SC Publishes Preclinical Data on Vidofludimus (4SC-101) in Peer-Review Journals'. It announces the publication of scientific results in external, peer-reviewed journals (Inflammatory Bowel Diseases and American Journal of Pathology). This is not a formal regulatory filing like a 10-K, IR, or ER. It is an announcement about scientific progress and data dissemination, which fits best under general Regulatory Filings (RNS) as a miscellaneous corporate news item, or potentially Investor Presentation (IP) if it were a slide deck, but since it's a press release announcing external publications, RNS is the most appropriate general category for non-standard corporate news releases not covered by other specific codes (like DIV, DIRS, MANG, etc.). Given the options, RNS serves as the best fit for this type of scientific update press release.
2010-04-28 English
4SC and Nexigen Receive EUR 1.4 million Funding from the German Federal Ministry of Education and Research to Develop Peptide Cancer Therapeutics
Regulatory Filings Classification · 100% confidence The document is a press release dated April 16, 2010, announcing a cooperation between 4SC AG and Nexigen GmbH to develop cancer therapeutics, funded by the German Federal Ministry of Education and Research. It details a business development/collaboration, not a mandatory regulatory filing like a 10-K, an earnings report (ER), or a dividend announcement (DIV). It is a general corporate news item concerning business operations and potential future products. Since it does not fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), and it is a general announcement disseminated via DGAP, it falls best under the general 'Regulatory Filings' category as a miscellaneous corporate announcement, although 'RNS' (Regulatory News Service/General Regulatory Announcement) is often used for such press releases when a more specific code isn't available. Given the options, RNS serves as the best general regulatory/news announcement fallback.
2010-04-16 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.